Table 1.
Lymph node counts in respective regional stations in the present study using SME compared with data from the Dutch trial
| Present series (SME) | Dutch trial (Bunt et al36 n = 8) | ||
|---|---|---|---|
| Station | n | Median (IQR) | Mean (range) |
| 1 | 141 | 4 (2‐6) | 5.5 (3‐7) |
| 2a | 40 | 2 (0‐4) | 2.9 (0‐10) |
| 3 | 141 | 8.5 (4‐14) | 12.0 (3‐36) |
| 4saa | 40 | 2 (0‐4) | 12.6 (6‐21)c |
| 4sb | 141 | 2 (0‐7) | |
| 4d | 141 | 8 (4‐11) | |
| 5 | 141 | 1 (0‐1) | 1.0 (0‐4) |
| 6 | 141 | 9 (5‐14) | 6.0 (5‐7) |
| 7 | 141 | 3 (1‐5) | 4.0 (0‐8) |
| 8 | 141 | 4 (2‐5) | 4.0 (2‐7) |
| 9 | 141 | 4 (2‐4) | 5.3 (3‐9) |
| 10b | 125 | 5 (1‐6) | 2.5 (0‐6) |
| 11p | 141 | 3 (1‐5) | 5.7 (0‐21)d |
| 11da | 40 | 2 (0‐4) | |
| 12 | 141 | 1 (0‐1) | No data |
| Sum | 58.5 | 59.8 | |
a
Removed in TG (n = 40).
b
Removed in TG + splenectomy or splenopancreatectomy (n = 24).
c
Expressed as the total number of lymph nodes at the no. 4 station.
d
Expressed as the total number of lymph nodes at the no. 11 station.
IQR, interquartile range; SME, systematic mesogastric excision; TG, total gastrectomy.